Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients

PLoS One. 2022 Aug 10;17(8):e0272572. doi: 10.1371/journal.pone.0272572. eCollection 2022.

Abstract

Background: Venous phlebotomy performed by trained personnel is critical for patient diagnosis and monitoring of chronic disease, but has limitations in resource-constrained settings, and represents an infection control challenge during outbreaks. Self-collection devices have the potential to shift phlebotomy closer to the point of care, supporting telemedicine strategies and virtual clinical trials. Here we assess a capillary blood micro-sampling device, the Tasso Serum Separator Tube (SST), for measuring blood protein levels in healthy subjects and non-hospitalized COVID-19 patients.

Methods: 57 healthy controls and 56 participants with mild/moderate COVID-19 were recruited at two U.S. military healthcare facilities. Healthy controls donated Tasso SST capillary serum, venous plasma and venous serum samples at multiple time points, while COVID-19 patients donated a single Tasso SST serum sample at enrolment. Concentrations of 17 protein inflammatory biomarkers were measured in all biospecimens by Ella multi-analyte immune-assay.

Results: Tasso SST serum protein measurements in healthy control subjects were highly reproducible, but their agreements with matched venous samples varied. Most of the selected proteins, including CRP, Ferritin, IL-6 and PCT, were well-correlated between Tasso SST and venous serum with little sample type bias, but concentrations of D-dimer, IL-1B and IL-1Ra were not. Self-collection at home with delayed sample processing was associated with significant concentrations differences for several analytes compared to supervised, in-clinic collection with rapid processing. Finally, Tasso SST serum protein concentrations were significantly elevated in in non-hospitalized COVID-19 patients compared with healthy controls.

Conclusions: Self-collection of capillary blood with micro-sampling devices provides an attractive alternative to routine phlebotomy. However, concentrations of certain analytes may differ significantly from those in venous samples, and factors including user proficiency, temperature control and time lags between specimen collection and processing need to be considered for their effect on sample quality and reproducibility.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Proteins
  • Blood Specimen Collection
  • COVID-19* / diagnosis
  • Healthy Volunteers
  • Humans
  • Reproducibility of Results
  • Specimen Handling

Substances

  • Blood Proteins

Grants and funding

This project was supported by the Joint Program Executive Office (JPEO-EB) W911QY-253 20-9-0004 (2020 OTA; awarded to DVC), in collaboration with the Johns Hopkins University School of Medicine COVID-19 Research Fund, the Office of the Assistant Secretary of Defense for Health Affairs, and the Bureau of Medicine and Surgery (DoD - Navy) Cooperative Agreement N626451920001 (awarded to DVC). URLs: https://urldefense.com/v3/__https://www.jpeocbrnd.osd.mil__;!!FykDdelvMO2VvRk!31OG3Kaw04QEx_ArLaNzcni4zJQH4Icyc96qsWExh62li_Td4EfTlNHhrtdwvgnAnoXTn94jXPz9HF22ZXh-ng$ https://urldefense.com/v3/__https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency__;!!FykDdelvMO2VvRk!31OG3Kaw04QEx_ArLaNzcni4zJQH4Icyc96qsWExh62li_Td4EfTlNHhrtdwvgnAnoXTn94jXPz9HF1DsRj5ng$ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.